{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:15:37Z","timestamp":1648779337760},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/mnm.0b013e3283299992","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T14:06:59Z","timestamp":1242914819000},"page":"263-269","source":"Crossref","is-referenced-by-count":3,"title":["Thyroid remnant ablation in patients with papillary cancer: a comparison of low, moderate, and high activities of radioiodine"],"prefix":"10.1097","volume":"30","author":[{"given":"Sanja","family":"Kusacic Kuna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Samardzic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanja","family":"Tesic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Medvedec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krunoslav","family":"Kuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Bracic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Despot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damir","family":"Dodig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210212","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0889-8529(18)30317-7","article-title":"Radioiodine-131 in the diagnosis and treatment of metastatic well diferentiated thyroid cancer","volume":"19","author":"Maxon","year":"1990","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R2-3-20210212","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4158\/EP.6.5.401","article-title":"Management of thyroid cancer: radioiodine ablation, stunning, and treatment of thyroglobulin-positive, (131)I scan-negative patients","volume":"6","author":"Hurley","year":"2000","journal-title":"Endocr Pract"},{"key":"R3-3-20210212","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2003-031167","article-title":"A systematic review and meta-analysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer","volume":"89","author":"Sawka","year":"2004","journal-title":"J Clin Endocrin Metab"},{"key":"R4-3-20210212","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/thy.1997.7.265","article-title":"Thyroid remnant I-131 ablation for papillary and follicular thyroid carcinoma","volume":"7","author":"Mazzaferri","year":"1997","journal-title":"Thyroid"},{"key":"R5-3-20210212","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4158\/EP.7.3.202","article-title":"Medical\/surgical guidelines for clinical practice: management of thyroid carcinoma","volume":"7","year":"2001","journal-title":"Endocr Pract"},{"key":"R6-3-20210212","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF03343960","article-title":"Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone","volume":"25","author":"Berg","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"R7-3-20210212","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1210\/jcem.87.4.8338","article-title":"Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?","volume":"87","author":"Mazzaferri","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-3-20210212","first-page":"1132","article-title":"Radioiodine 131 therapy for well-differentiated thyroid cancer \u2013 a quantitative radiation dosimetric approach: outcome and validation in 85 patients","volume":"33","author":"Maxon","year":"1992","journal-title":"J Nucl Med"},{"key":"R9-3-20210212","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/thy.1999.9.387","article-title":"Short-term effectiveness of low-dose radioiodine ablative treatment of thyroid remnants after thyreoidectomy for differentiated thyroid cancer","volume":"9","author":"Vermiglio","year":"1999","journal-title":"Thyroid"},{"key":"R10-3-20210212","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2574::AID-CNCR22>3.0.CO;2-O","article-title":"Prospective randomized clinical trial to evaluate the optimal dose of 131-I for remnant ablation in patients with different thyroid carcinoma","volume":"77","author":"Bal","year":"1996","journal-title":"Cancer"},{"key":"R11-3-20210212","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00006231-199610000-00003","article-title":"Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose 131I","volume":"17","author":"Huic","year":"1996","journal-title":"Nucl Med Commun"},{"key":"R12-3-20210212","first-page":"281","article-title":"I-131 total body burden in postsurgical patients with thyroid cancer","volume":"32","author":"Medvedec","year":"1998","journal-title":"Radiol Oncol"},{"key":"R13-3-20210212","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.mnm.0000169380.92270.73","article-title":"Thyroid stunning in vivo and in vitro","volume":"26","author":"Medvedec","year":"2005","journal-title":"Nucl Med Commun"},{"issue":"2","key":"R15-3-20210212","first-page":"16","article-title":"Has come the day to do away with thyroid remnant ablation targeting 300 gray (Gy)?","volume":"48","author":"Medvedec","year":"2007","journal-title":"J Nucl Med"},{"issue":"2","key":"R16-3-20210212","first-page":"8","article-title":"High ablation success rate achieved by the lowest I-131 activity to date","volume":"49","author":"Medvedec","year":"2008","journal-title":"J Nucl Med"},{"key":"R17-3-20210212","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s002590050490","article-title":"Nuclear medicine and thyroid cancer","volume":"26","author":"Jana","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"R18-3-20210212","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1210\/jc.2004-0920","article-title":"Patients with differentiated thyroid carcinoma benefit from radioiodine remnant ablation","volume":"89","author":"Haugen","year":"2004","journal-title":"J Clin Endocrin Metab"},{"key":"R19-3-20210212","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1210\/jc.2005-1651","article-title":"Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study","volume":"91","author":"Pacini","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-3-20210212","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1210\/jc.2003-031152","article-title":"Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients","volume":"89","author":"Bal","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-3-20210212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1210\/jc.2006-1345","article-title":"131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review","volume":"92","author":"Hackshaw","year":"2007","journal-title":"J Clin Endocrin Metab"},{"key":"R22-3-20210212","first-page":"1287","article-title":"An analysis of ablation of thyroid remnants with I-131 in patients from 1947\u20131984: experience at University of Michigan","volume":"25","author":"Bierwaltes","year":"1984","journal-title":"J Nucl Med"},{"key":"R23-3-20210212","first-page":"1546","article-title":"Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma","volume":"39","author":"Muratet","year":"1998","journal-title":"J Nucl Med"},{"key":"R24-3-20210212","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02984614","article-title":"Outcome of ablation of thyroid remnants with 100\u2009mCi (3.7\u2009GBq) iodine-131 in patients with thyroid cancer","volume":"19","author":"Rosario","year":"2005","journal-title":"Ann Nucl Med"},{"key":"R25-3-20210212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00006231-200502000-00008","article-title":"Ablative treatment of thyroid cancer with high doses of 131I without pre-therapy scanning","volume":"26","author":"Rosario","year":"2005","journal-title":"Nucl Med Commun"},{"key":"R26-3-20210212","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00006231-200006000-00005","article-title":"Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy","volume":"21","author":"De Klerk","year":"2000","journal-title":"Nucl Med Commun"},{"key":"R27-3-20210212","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00006231-200305000-00002","article-title":"Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates","volume":"24","author":"Karam","year":"2003","journal-title":"Nucl Med Commun"},{"key":"R28-3-20210212","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/00006231-200109000-00012","article-title":"Post-surgical ablation of thyroid remnants with high-dose 131I in patients with differentiated carcinoma","volume":"22","author":"Arslan","year":"2001","journal-title":"Nucl Med Commun"},{"key":"R29-3-20210212","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3121\/cmr.2007.763","article-title":"Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited","volume":"5","author":"Doi","year":"2007","journal-title":"Clin Med Res"},{"issue":"1","key":"R30-3-20210212","first-page":"278","article-title":"Early evaluation of treatment effectiveness using 131-I iodine radiotherapy in patients with differentiated thyroid cancer","volume":"54","author":"Gawkowska-Suwinska","year":"2001","journal-title":"Wiad Lek"},{"key":"R31-3-20210212","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2265.2000.01014.x","article-title":"Ablation of the thyroid remnant and 131-I dose in differentiated thyroid cancer","volume":"52","author":"Doi","year":"2000","journal-title":"Clin Endocrinol"},{"key":"R32-3-20210212","first-page":"252","article-title":"Comparison of 1073 and 3700\u2009MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer","volume":"32","author":"Johansen","year":"1991","journal-title":"J Nucl Med"},{"key":"R33-3-20210212","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0002-9343(76)90030-9","article-title":"Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer","volume":"61","author":"McCowen","year":"1976","journal-title":"Am J Med"},{"key":"R34-3-20210212","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/eje.1.02014","article-title":"Post-surgical use of radioiodine (131-I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report","volume":"153","author":"Pacini","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R35-3-20210212","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/00006231-200411000-00002","article-title":"Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake","volume":"25","author":"Rosario","year":"2004","journal-title":"Nucl Med Commun"},{"key":"R36-3-20210212","first-page":"1927","article-title":"Assessment of the efficacy of iodine-131 for thyroid ablation","volume":"34","author":"Comtois","year":"1993","journal-title":"J Nucl Med"},{"key":"R37-3-20210212","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00006231-199603000-00005","article-title":"What is the role of 1100\u2009MBq (<30\u2009mCi) radioiodine 131I in treatment of patients with differentiated thyroid cancer?","volume":"17","author":"Van Wyngaarden","year":"1996","journal-title":"Nucl Med Commun"},{"key":"R38-3-20210212","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1210\/jc.2007-0225","article-title":"A comparison of 1850\u2009MBq (50\u2009mCi) and 3700\u2009MBq (100\u2009mCi) 131-iodine administered doses for recombinant TSH-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer","volume":"92","author":"Pilli","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-3-20210212","article-title":"International basic safety standards for protection against opnizing radiation and for the safety of radiation sources","year":"1996"},{"key":"R40-3-20210212","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00259-002-0785-6","article-title":"Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic I-131 and I-123","volume":"29","author":"Hilditch","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R41-3-20210212","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1160\/nukmed-0285","article-title":"Procedure guidelines for iodine-131 scintigraphy for differentiated thyroid cancer (version 3)","volume":"46","author":"Dietlein","year":"2007","journal-title":"Nuklearmedizin"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006231-200904000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:46:10Z","timestamp":1618037170000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-200904000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e3283299992","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}